Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424

To report the long-term outcomes of the YYY1 study of a high-risk low-grade gliomas (LGG) population treated with concurrent and adjuvant temozolomide (TMZ) and radiotherapy (RT).
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research